WO2012031785A2 - Composite particle active and method for making the same - Google Patents

Composite particle active and method for making the same Download PDF

Info

Publication number
WO2012031785A2
WO2012031785A2 PCT/EP2011/053740 EP2011053740W WO2012031785A2 WO 2012031785 A2 WO2012031785 A2 WO 2012031785A2 EP 2011053740 W EP2011053740 W EP 2011053740W WO 2012031785 A2 WO2012031785 A2 WO 2012031785A2
Authority
WO
WIPO (PCT)
Prior art keywords
calcium
composite particle
particle active
core
teeth
Prior art date
Application number
PCT/EP2011/053740
Other languages
French (fr)
Other versions
WO2012031785A3 (en
Inventor
Yan Deng
Guanjun Ding
Xiaoke Li
Original Assignee
Unilever Plc
Unilever N.V.
Hindustan Unilever Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Plc, Unilever N.V., Hindustan Unilever Limited filed Critical Unilever Plc
Priority to US13/820,154 priority Critical patent/US20130164359A1/en
Priority to BR112013004354A priority patent/BR112013004354B8/en
Priority to CN2011800433996A priority patent/CN103079645A/en
Priority to EP11710153.5A priority patent/EP2613850B1/en
Publication of WO2012031785A2 publication Critical patent/WO2012031785A2/en
Publication of WO2012031785A3 publication Critical patent/WO2012031785A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • A61K8/0254Platelets; Flakes
    • A61K8/0258Layered structure
    • A61K8/0262Characterized by the central layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • A61K8/0275Containing agglomerated particulates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29Titanium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09CTREATMENT OF INORGANIC MATERIALS, OTHER THAN FIBROUS FILLERS, TO ENHANCE THEIR PIGMENTING OR FILLING PROPERTIES ; PREPARATION OF CARBON BLACK  ; PREPARATION OF INORGANIC MATERIALS WHICH ARE NO SINGLE CHEMICAL COMPOUNDS AND WHICH ARE MAINLY USED AS PIGMENTS OR FILLERS
    • C09C1/00Treatment of specific inorganic materials other than fibrous fillers; Preparation of carbon black
    • C09C1/36Compounds of titanium
    • C09C1/3607Titanium dioxide
    • C09C1/3653Treatment with inorganic compounds
    • C09C1/3661Coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/412Microsized, i.e. having sizes between 0.1 and 100 microns
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60Particulates further characterized by their structure or composition
    • A61K2800/61Surface treated
    • A61K2800/62Coated
    • A61K2800/621Coated by inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60Particulates further characterized by their structure or composition
    • A61K2800/61Surface treated
    • A61K2800/62Coated
    • A61K2800/622Coated by organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60Particulates further characterized by their structure or composition
    • A61K2800/65Characterized by the composition of the particulate/core
    • A61K2800/651The particulate/core comprising inorganic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/51Particles with a specific particle size distribution

Definitions

  • the present invention is directed to a composite particle active and method for making the composite particle. More particularly, the invention is directed to composite particle active suitable for use in the mouth to, at the very least, aid in the remineralization and whitening of teeth by interacting with phosphate ions and delivering calcium and phosphate sources to the teeth of consumers.
  • the particles therefore, are suitable for use in compositions that are used in the mouth. Such particles can, for example, be used in a toothpaste or gel composition, mouthwash, as well as chewing gum compositions.
  • the composite particle active of this invention comprises a first component core suitable to immediately improve an oral care characteristic and a second component coating that is suitable to interact with phosphate ions to produce calcium and phosphate in situ reaction products that surprisingly adhere well to teeth to provide immediate and long term benefits.
  • Such products often comprise peroxides, abrasives or both in order to clean and whiten teeth. These types of products are often not desired since they do not contribute to the remineralization of teeth and can cause damage to teeth and gums if overused. Products comprising calcium sources have been developed in an attempt to enhance the characteristics of teeth. Such products, however, do not positively adhere to teeth and thereby may only contact teeth for a brief period prior to being rinsed out of the mouth in wash water.
  • the composite particle actives of the present invention comprises a first component core for immediately improving an oral care characteristic and a second component coating that is suitable to interact with phosphate ions to produce calcium and phosphate in situ reaction products that surprisingly adhere well to teeth for both immediate and long term benefits.
  • the present invention is directed to a composite particle active comprising:
  • the present invention is directed to a method for making the composite particle active of the first aspect of this invention.
  • Soluble and insoluble refers to the solubility of a source (e.g., like calcium) in water.
  • Soluble means a source that dissolves in water to give a solution with a concentration of at least 0.1 moles per liter at room temperature.
  • Insoluble means a source that dissolves in water to give a solution with a concentration of less than 0.001 moles per liter at room temperature.
  • Slightly soluble therefore, is defined to mean a source that dissolves in water to give a solution with a concentration of greater than 0.001 moles per liter at room temperature and less than 0.1 moles per liter at room temperature.
  • Oral care composition means a composition suitable for use in the mouth and for veterinary and/or human applications but especially for use in applications for the human mouth.
  • Benefitting teeth means at the very least whitening, remineralization or desensitizing teeth or decreasing bacteria within the mouth where the decreasing of bacteria can be the result of employing an antimicrobial agent and the desensitizing of teeth is the result of composite particle active interacting with phosphate ions found in the mouth and/or within the oral care composition and adhering to the teeth to, for example, yield new hydroxyapatite formation on dentinal tubules. Diameter is meant to mean the longest distance measurable in the event the composite particle active is not a perfect sphere.
  • Remineralization as used herein, means the in situ generation of hydroxyapatite on teeth to reduce the likelihood of tooth decay and improve the appearance of teeth by whitening through the generation of such new hydroxyapatite.
  • Single-phase composition means a one phase composition having both calcium and phosphate sources therein and prior to dispensing or unpackaging and use.
  • Anhydrous as used herein, means substantially free of water (e.g., no water to less than 5% by weight water and preferably less than 1 % by weight water).
  • Dual-phase product means having required and complementary calcium and phosphate hydroxyapatite precursors in separate compositions and stored in separate compartments.
  • Composition as used herein includes, for example, paste, powder, gel, liquid (like mouthwash), spray, foam, balm, a composition carried on a mouthstrip or a buccal adhesive patch, chewable tablet (or pastille), lozenge, cream, beverage or a strip of gum.
  • the composition is a paste like toothpaste or a gel for teeth.
  • Carrier as used herein, means a component in the composition other than the composite particle active and phosphate source whereby the carrier is suitable to deliver the active and any phosphate source present therein.
  • First component core as used herein, is meant to include the portion of the composite particle active that is coated whereby the core can comprise particle or an aggregate of particle like, for example, an agglomerate of ⁇ 2.
  • Core is also meant to include a component that provides immediate (e.g., within three (3) uses of the composition, but preferably, within 1 second to 5 minutes of using) whitening benefits to teeth via physical mechanisms.
  • Long term benefit is meant to include a benefit that will last at least for weeks, but preferably, at least four (4) months.
  • the core is meant to be a component that may improve a characteristic of teeth.
  • Second component coating means a coating that forms an external coat or clad on at least a portion of the first component core.
  • adhering as used herein, can include effectively depositing and/or bonding or "sticking" to teeth as a result of calcium in the coating of the composite particle active and phosphate ion interactions.
  • Coating is also meant to include a component that provides benefits to teeth over time through biological or chemical mechanisms like the formation of hydroxyapatite.
  • Composite particle active therefore, is meant to mean a particle that may provide both immediate and long term benefits to teeth after use.
  • In situ reaction product means a product comprising calcium and phosphate generated in the mouth. All ranges defined herein are meant to include all ranges subsumed therein unless specifically stated otherwise. Comprising, as used herein, is meant to include consisting essentially of and consisting of, and should be understood to not preclude the inclusion of other components.
  • Figure 1 shows composite particle active adhesion to enamel after one treatment.
  • Figure 2 shows composite particle active adhesion to enamel after fourteen treatments.
  • Figure 3 shows composite particle active adhesion to dentin after one treatment.
  • Figure 4 shows composite particle active adhesion to dentin after fourteen treatments.
  • Figure (A and B) shows conventional silicone and composition particle active deposition on the surface of teeth
  • Figure 6 (a-d) shows Transmission Election Microscopy Images of uncoated and coated titanium dioxide particles
  • Figure 7 shows results from a consumer tooth whitening study after 2 weeks and 4 weeks treatment as compared to baseline.
  • the core of the composite particle active comprises a material suitable to physically and immediately improve characteristics of teeth, and especially, whiten teeth.
  • a material typically has an index of refraction from 1 .2 to 3, preferably, from 1 .3 to 2.8, and most preferably, from 1 .5 to 2.8, including all ranges subsumed therein.
  • Illustrative yet non-limiting examples of such core materials that are suitable to physically improve teeth include silica, titanium dioxide, zinc oxide, mica (including coated mica like commercially available iron oxide coated mica), calcium carbonate, barium sulfate or a mixture thereof.
  • the core of the composite particle active typically makes up from 3 to 98%, and preferably, from 6 to 65%, and most preferably, from 10 to 55% by weight of the composite particle active, based on total weight of the composite particle active and including all ranges subsumed therein.
  • the core of the composite particle active typically makes up from 3 to 98%, and preferably, from 6 to 65%, and most preferably, from 10 to 55% by weight of the composite particle active, based on total weight of the composite particle active and including all ranges subsumed therein.
  • the core is at least 50% by weight titanium dioxide or zinc oxide, and most preferably, from 60 to 100% by weight titanium dioxide or zinc oxide, based on total weight of the first component core.
  • the coating suitable to adhere to tooth enamel, dentin or both typically comprises a metal element such as calcium, and optionally, other metals like potassium, sodium, aluminum, magnesium, as well as mixtures thereof.
  • the same is suitable to provide a biological or chemical improvement to teeth which is both long and short term (e.g., results in whitening and hydroxyapatite formation).
  • the coating employed comprises at least 50% by weight elemental calcium, and most preferably, at least 65% by weight elemental calcium based on total weight of metal in the coating.
  • the metal element in the coating is from 80 to 100% by weight elemental calcium, based on total weight of metal in the second component coating and including all ranges subsumed therein.
  • the core and the coating are slightly soluble or insoluble in water, but most preferably, insoluble in water.
  • At least 5% of the outer surface of the core is coated with coating, and preferably, at least 50% of the core is covered with coating. In a most preferred embodiment, 70 to 100% of the outer surface area of the first component core is coated with the second component coating.
  • the diameter of the composite particle active is often from 10 nm to less than 50 microns, and preferably, from 75 nm to less than 10 microns. In an especially preferred embodiment, the diameter of composite particle active is from 500 nm to 5 microns, including all ranges subsumed therein. In yet another especially preferred embodiment, at least 40%, and preferably, at least 60%, and most preferably, from 75 to 99.5% of the diameter of the composite particle active is the result of core, including all ranges subsumed therein.
  • An oral care composition suitable to carry the composite particle active of this invention usually comprises from 0.25 to 40%, and preferably, from 0.5 to 20%, and most preferably, from 0.5 to 15% by weight composite particle active, based on total weight of the oral care composition and including all ranges subsumed therein.
  • the composition comprises an overall metal (e.g., calcium ion) content of less than 40%, and preferably, less than 30%, and most preferably, from 1 to 25% by weight metal element, based on total weight of the composition and including all ranges subsumed therein.
  • composite particle active may be added to a composition along with an additional metal source like a calcium source.
  • Such an additional metal source may be identical to that which is used to coat the core of the composite particle active (e.g., calcium silicate or calcium oxide).
  • the additional metal source typically makes up from 0.1 to 35%, and preferably, from 1 to 25%, and most preferably, from 10 to 20% by weight of the total weight of the oral care composition and including all ranges subsumed therein.
  • the second component coating can comprise, for example, calcium phosphate, calcium gluconate, calcium oxide, calcium lactate, calcium carbonate, calcium hydroxide, calcium sulfate, calcium carboxymethyl cellulose, calcium alginate, calcium salts of citric acid, calcium silicate, mixtures thereof or the like.
  • the calcium source in the coating will comprise calcium silicate.
  • These compounds are also suitable to include as reagents for calcium sources when making the composite particle active of this invention. Similar salts with sodium, magnesium, aluminum and potassium in lieu of calcium may, for example, be used as reagents to provide the anionic portion of the second component coating during particle
  • the coating can comprise a calcium source which is insoluble calcium silicate, present as the composite material calcium oxide-silica (CaO-SiO2) as described in commonly-owned applications, World Application Nos. 2008/0151 17 and 2008/068248.
  • a calcium source which is insoluble calcium silicate, present as the composite material calcium oxide-silica (CaO-SiO2) as described in commonly-owned applications, World Application Nos. 2008/0151 17 and 2008/068248.
  • the ratio of calcium to silicon may be from 1 : 10 to 3:1 .
  • the Ca:Si ratio is preferably from 1 :5 to 2:1 , and more preferably, from 1 :3 to 2:1 , and most preferably, from about 1 :2 to 2:1 .
  • the calcium silicate may comprise mono- calcium silicate, bi-calcium silicate, or tri-calcium silicate whereby ratios of calcium to silicon (Ca:Si) should be understood to be atom ratios.
  • the preferred calcium source employed in this invention to generate second component coating on the composite particle active may be in a crystalline or amorphous state.
  • the calcium source for coating is in a mesoporous state, i.e. the source is a material having pores with diameters from 1 nm to 1 micron.
  • Mesoporous calcium silicate (MCS) is often preferred.
  • the MCS which may be used in second component coating in this invention can be made by combining a calcium salt (e.g., calcium chloride, calcium carbonate, calcium hydroxide), a silica precursor like silicate (e.g., sodium silicate, potassium silicate, tetraethyl orthosilicate or tetraethylsilicate) and a structure-directing agent to yield a solid suitable for calcinating.
  • a calcium salt e.g., calcium chloride, calcium carbonate, calcium hydroxide
  • silica precursor like silicate e.g., sodium silicate, potassium silicate, tetraethyl orthosilicate or tetraethylsilicate
  • a structure-directing agent e.g., sodium silicate, potassium silicate, tetraethyl orthosilicate or tetraethylsilicate
  • oral care compositions comprising the composite particle active of this invention further comprise a phosphate source.
  • the phosphate source that may be used in this invention is limited only to the extent that the same may be used in a composition suitable for use in the mouth.
  • Illustrative examples of the types of phosphate source suitable for use in this invention and added along with the composite particle actives described include monosodium phosphate, sodium dihydrogen phosphate, disodium hydrogen phosphate, sodium pyrophosphate, tetrasodium
  • the phosphate source is preferably one which is water soluble.
  • the phosphate source When used, the phosphate source typically makes up from 0.5 to 22%, and preferably, from 2 to 18%, and most preferably, from 4 to 16% by weight of the oral care composition, based on total weight of the oral care composition and including all ranges subsumed therein.
  • the phosphate source used is one which results in an oral care composition (i.e., combined composition if a dual phase product) having a pH from 5.5 to 8, preferably from 6 to 7.5, and most preferably, about neutral.
  • the phosphate source used is trisodium phosphate and monosodium dihydrogen phosphate at a trisodium phosphate to monosodium dihydrogen phosphate weight ratio of 1 :4 to 4:1 , preferably 1 :3 to 3:1 , and most preferably, from 1 :2 to 2:1 , including all ratios subsumed therein.
  • Oral care compositions for benefitting teeth and comprising the composite particle active of this invention may comprise optional ingredients which are common in the art. These ingredients include: ⁇ antimicrobial agents, e.g. Triclosan, chlorhexidine, copper-, zinc- and stannous salts such as zinc citrate, zinc sulphate, zinc glycinate, sodium zinc citrate and stannous pyrophosphate, sanguinarine extract, metronidazole, quaternary ammonium compounds, such as cetylpyridinium chloride; bis-guanides, such as chlorhexidine digluconate, hexetidine, octenidine, alexidine; and halogenated bisphenolic compounds such as 2,2' methylenebis-(4-chloro-6- bromophenol); anti-inflammatory agents such as ibuprofen, flurbiprofen, aspirin, indomethacin, etc.; ⁇ anti-caries agents such as sodium trimetaphosphate and casein;
  • ⁇ plaque buffers such as urea, calcium lactate, calcium
  • vitamins such as Vitamins A, C and E;
  • ⁇ desensitizing agents e.g. potassium citrate, potassium chloride, potassium tartrate, potassium bicarbonate, potassium oxalate, and potassium nitrate;
  • ⁇ anti-calculus agents e.g. alkali-metal pyrophosphates
  • hypophosphite-containing polymers organic phosphonates and phosphocitrates, etc.
  • biomolecules e.g. bacteriocins, antibodies, enzymes, etc.
  • ⁇ flavors e.g., peppermint and spearmint oils
  • ⁇ proteinaceous materials such as collagen
  • ⁇ colouring agents like FD&C blue, yellow and/or red dyes/colorants
  • ⁇ pH-adjusting agents such as sodium lauryl sulfate, sodium dodecylbenzene sulfonate
  • surfactants such as anionic, nonionic, cationic and zwitterionic or amphoteric surfactants (e.g., sodium lauryl sulfate, sodium dodecylbenzene sulfonate); particulate abrasive materials such as abrasive silicas, aluminas, calcium carbonates, zirconium silicate, polymethylmethacrylate, dicalciumphosphates, calcium pyrophosphates, hydroxyapatites, trimetaphosphates, insoluble hexametaphosphates as well as agglomerated particulate abrasive materials; fluoride sources like sodium fluoride, stannous fluoride, sodium monofluorophosphate, zinc ammonium fluoride, tin ammonium fluoride, calcium fluoride, cobalt ammonium fluoride
  • polymers examples include copolymers of polyvinylmethylether with maleic anhydride and other similar delivery enhancing polymers, e.g., those described in DE-A03,942,643; buffers and salts to buffer the pH and ionic strength of the oral care compositions; and other optional ingredients that may be included are, e.g., bleaching agents such as peroxy compounds, e.g., potassium
  • peroxydiphosphate, effervescing systems such as sodium
  • Such ingredients typically and collectively make-up less than 20% by weight of the oral care composition comprising the composite particle active of this invention, and preferably, from 0.0 to 15% by weight, and most preferably, from 0.01 to 12% by weight of the oral care composition, including all ranges subsumed therein.
  • Thickener may also be used in this invention and is limited only to the extent that the same may be added to a composition suitable for use in the mouth along with the composite particle actives of this invention.
  • Illustrative examples of the types of thickeners that may be used in this invention include, sodium carboxymethyl cellulose, hydroxyl ethyl cellulose, methyl cellulose, ethyl cellulose, gum tragacanth, gum Arabic, gum karaya, sodium alginate, carrageenan, guar, xanthan gum, Irish moss, starch, modified starch, silica based thickeners including silica aerogels, magnesium aluminum silicate (i.e., Veegum) Carbomers (cross- linked acrylates) and mixtures thereof.
  • silica based thickeners including silica aerogels, magnesium aluminum silicate (i.e., Veegum) Carbomers (cross- linked acrylates) and mixtures thereof.
  • sodium carboxymethyl cellulose and/or a Carbomer is/are preferred.
  • a Carbomer those having a molecular weight of at least 700,000 are desired, and preferably, those having a molecular weight of at least 1 ,200,000, and most preferably, those having a molecular weight of at least about 2,500,000 are desired.
  • Mixtures of Carbomers may also be used herein.
  • the Carbomer is Carbopol ® 980. It has been described as a high molecular weight and cross-linked polyacrylic acid and identified via CAS number 9063-87-0. The same is available commercially from Lubrizol Advanced Materials, Inc.
  • the sodium carboxymethyl cellulose (SCMC) used is SCMC 9H. It has been described as a sodium salt of a cellulose derivative with carboxymethyl groups bound to hydroxy groups of glucopyranose backbone monomers and identified via CAS number 9004-32-4. The same is available from suppliers like Alfa Chem.
  • Thickener typically makes up from 0.01 to about 10%, and preferably, from 0.1 to 8%, and most preferably, from 1 .5 to 6% by weight of the oral care composition, based on total weight of the oral care composition and including all ranges subsumed therein.
  • Suitable carriers that may be employed in this invention are, for example, glycerin, sorbitol, propylene glycol, dipropylene glycol, diglycerol, triacetin, mineral oil, polyethylene glycol (preferably, PEG-400), alkane diols like butane diol and hexanediol, ethanol, pentylene glycol, or a mixture thereof.
  • the carriers should, in any case, be substantially free of water, and preferably, anhydrous if a single phase product comprising phosphate as an additive and composite particle active are desired.
  • the carrier can, for example, be used in solid form, but glycerin is often the preferred carrier or humectant in single phase products.
  • the carrier is used to take the balance of the single phase compositions up to 100%, and the same may be present in the range from 10 to 90% by weight of the single phase oral care composition.
  • carrier makes up from 25 to 80%, and most preferably, from 45 to 70% by weight of the single phase oral care composition, based on total weight of the single phase oral care composition and including all ranges subsumed therein.
  • a dual phase oral care composition is recommended to prevent interaction (prior to use) between the phosphate and second component coating of the composite particle active.
  • water may act as a carrier (along with thickeners and/or additional carriers herein described) and make up the balance of each composition in the dual phase product wherein a first composition will comprise composite particle active and a second composition will comprise the added phosphate source.
  • first and second compositions should not come into contact with each other until dispensed for use by the consumer in his or her mouth.
  • the weight percents described herein are meant to characterize the oral care composition after the first and second compositions have been combined.
  • the delivery of each composition (in the event a dual composition product is desired) may be sequential or simultaneous, but preferably, simultaneous.
  • each composition within the dual phase oral care composition comprises less than 35% by weight water, and most preferably, from 15 to 25% by weight water, based on total weight of each composition and including all ranges subsumed therein.
  • One or preferably both of the compositions within the dual phase oral care composition may be applied to the teeth, with treatment of the teeth involving mixing of the compositions. Whether single or dual phase, the compositions are preferably left on the teeth following application. Following such application, the oral care compositions of this invention should typically be left on the teeth for 5 seconds to 10 hours and more typically from 35 seconds to 30 minutes. The application may be carried out daily. If a dual composition is employed, the same may be applied from independent compartments at a dual compartment tube or from independent phases of a product contained within a single container which is typically a tube.
  • the means of delivery may optionally involve a tape, in particular an adhesive tape strip, onto which the compositions of this invention are applied prior to the strip being placed in contact with the teeth.
  • a tape in particular an adhesive tape strip
  • the compositions can be held in close contact with the surface of the teeth, facilitating a high concentration of composite particle active and phosphate close to the surface of the teeth.
  • the same typically comprises a polymeric matrix, and is more typically a hydrogel.
  • the polymeric matrix is typically present at from 1 to 25% by weight of the composition of which it is a part.
  • Monomers used to prepare hydrogels may be selected from, for example, vinyl alcohol and acrylate, in particular sodium acrylate. Other monomers comprising an abundance of hydrophilic groups may also be used.
  • hydrogels comprise a polysaccharide, polyacrylamide, polyacrylic acid, or a mixture thereof.
  • Suitable polysaccharides may be storage polysaccharides, such as starch or glycogen, or structural polysaccharides, such as cellulose or chitin.
  • Illustrative polysaccharides which may be used include those having saccharide units selected from one or more of the following: isomaltose, glucose, fructose, galactose, xylose, mannose, sorbose, arabinose, rhamnose, fucose, maltose, sucrose, lactose, maltulose, ribose, lyxose, allose, altrose, gulose, idose, talose, trehalose, nigerose, kojibiose, and lactulose.
  • hydrogels comprise at least one polysaccharide selected from the group consisting of: tamarind gum, guar gum, locust bean gum, Tara, Fenugreek, Aloe, Chia, Flaxseed, Psyllium seed, quince seed, xanthan, gellan, welan, rhamsan, dextran, curdlan, pullulan, scleroglucan, schizophyllan, chitin, hydroxyalkyl cellulose, arabinan, de-branched arabinan, arabinoxylan, glactan, pectic galactan, galactomannan, glucomannan, lichenan, mannan, pachyman, rhamnogalacturonan, acacia gum, agar, alginates, carrageenan, chitosan, clavan, hyaluronic acid, heparin, inulin, cellodextrins, cellulose, and cellulose derivatives.
  • Especially preferred hydrogels can comprise polysaccharides like those selected from the group consisting of: sodium alginate, hydroxypropyl alginate, gum carrageenan, gum arabic, guar gum, karaya gum, chitosan and pectin.
  • compositions comprising the composite particle actives of this invention (whether single or dual phase) are prepared by conventional methods of making oral care compositions. Such methods include mixing the ingredients under moderate shear and atmospheric pressure.
  • the compositions are desired for use in the mouth, and preferably, are of the form that may be brushed onto teeth with a toothbrush.
  • the oral care compositions of this invention result in excellent remineralization of teeth (i.e., new hydroxyapatite formation) and teeth whitening (which may be immediate and provided for by the core of the composite particle active) as a result of composite particle active adhering to enamel and/or dentin of teeth.
  • teeth are unexpectedly less sensitive, and shinier, the same also being a direct result of composite particle active adhering to the enamel and/or dentin of teeth.
  • the composite particle active of this invention may be prepared by creating a slurry comprising core material and solvent (e.g., low molecular weight ketones like acetone, low molecular weight alcohols like C3-6 alkanols, water or mixtures thereof), the slurry comprising 3 to 60%, and preferably, 5 to 30%, and most preferably, 5 to 20% by weight core material based on total weight of the slurry.
  • solvent e.g., low molecular weight ketones like acetone, low molecular weight alcohols like C3-6 alkanols, water or mixtures thereof
  • the core material (like titanium oxide or mica) slurry should be heated from 25 to 95°C, and preferably, from 55 to 95°C, and most preferably, from 70 to 90°C, including all ranges subsumed therein. While heating, precursor for anionic portion of coating (like sodium silicate or silica) should then be added to the heated slurry to provide for coating on core material.
  • precursor for anionic portion of coating like sodium silicate or silica
  • the curing of the anionic portion (i.e., anionic precursor portion) within the slurry should last from 0.5 hours to 3 hours, and preferably, from 0.5 hours to 1 hour at an alkaline pH (preferably 8.5 to pH 1 1 , and most preferably, 9 to pH 10.5).
  • slurry can be achieved under acidic conditions (i.e., preferably 3 to pH 5), for an additional 0.5 to 2 hours when the core material is not soluble in the slurry under such acidic conditions.
  • acidic conditions i.e., preferably 3 to pH 5
  • chemical metal material suitable to supply cations like calcium ions, should then be added to the resulting cured core slurry.
  • the resulting mixture with cations should be cured from 0.5 hours to 24 hours, and preferably, from 0.5 hours to 2 hours at a pH from 9 to 13 and at
  • anionic precursor reagents like sodium alginate and/or sodium sulfate can further be added for in situ generation of coating material within the slurry.
  • Slurry pH may be adjusted with conventional ingredients like NaOH or HCL. Mixing of ingredients may be achieved with conventional mixing apparatus. Often, however, a pipeline reactor having a zone of turbulence is often preferred.
  • Conventional catalysts or structure directing agents may be used to generate composite particle. These agents typically make up from 0.01 to 3% by weight of the slurry when they are used.
  • An often preferred agent is a cetyltrialkyl ammonium halide like
  • silica is used in the core material and solvent slurry for coating manufacture.
  • the resulting particles may be cleaned by conventional techniques which include filtration and/or centrifugation and subsequently dried.
  • the desired composite particles of this invention may be recovered by drying such resulting particles where drying may be accelerated with heat and usually takes about 10 minutes to two (2) hours when heating to a temperature in the range from 65°C to 1000°C.
  • the oral care composition of this invention is a toothpaste or gel
  • the same typically has a viscosity from about 50,000 to 180,000 centipoise, and preferably, from 60,000 to 170,000 centipoise, and most preferably, from 65,000 to 165,000 centipoise, taken at room temperature with a Brookfield Viscometer, Spindle No. 4.
  • the composition may be packaged in a
  • Solid dosage form types include pastilles, lozenges, chewing gums, tablets,
  • mouthstrips may be contained in conventional packaging desirable for consumer use.
  • a dual phase aqueous-based oral care composition for benefitting teeth and consistent with this invention (i.e., comprising composite particle active) was made by mixing the ingredients below under conditions of moderate shear, atmospheric pressure and ambient temperature.
  • the compositions made were suitable for use with a toothbrush, and when combined about equally were not gritty and resulted in an excellent ribbon when applied to a toothbrush.
  • the combined compositions, which resulted in the oral care composition of this invention, had consumer acceptable taste characteristics.
  • composite particle active coating ⁇ 10 nm; particle diameter ⁇ 100 to 300 nm
  • Enamel and dentin blocks (3 cm 2 ) were polished for at about 5 minutes using silicone carbide abrasive paper (1200 grit).
  • the dentin blocks were acid etched for 60 seconds using 36% phosphoric acid, followed by a water wash.
  • the blocks were purchased from a commercial supplier.
  • a slurry comprising 20% by weight calcium silicate and 4% by weight composite particle active (similar to the one described in Example 1 ) were added to a water balance to make a slurry.
  • a sodium phosphate slurry was made by adding 20% by weight sodium phosphate to a water balance.
  • the resulting slurries were homogenized for about 10 minutes using conventional stirring apparatus in order to yield homogeneous compositions.
  • the homogenized slurries were poured into petri dishes. Enough was used to cover the surface of the blocks which were placed in the dishes. The blocks were brushed with a toothbrush for 1 minute and incubated in the slurry for one minute. The blocks were subsequently washed with distilled water three times and further incubated in simulated oral cavity fluid for at about 2 hours in a 37°C water bath. Treatment for each block was repeated 14 times.
  • Figure 1A shows a scanning electron microscopy image of the enamel block after one treatment.
  • Composite particle active (circled) surprisingly is shown adhering to the surface of the enamel block after one treatment.
  • Figure 1 B shows an energy dispersive x-ray image (elemental maps, Ti Ka1 , 20KV) of the same block.
  • Composite particle active is shown as bright dots (circled) surprisingly adhering well to the enamel block after one treatment.
  • Figure 2A shows a scanning electron microscopy image of the enamel block after 14 treatments and
  • Figure 2B shows an energy dispersive x-ray image of the same block having received fourteen treatments. The results unexpectedly demonstrate excellent adhesion of the composite particle active to the enamel surface.
  • Figure 3A shows a scanning electron microscopy image of the dentin block after one treatment.
  • Composite particle active surprisingly is shown adhering to the surface of the dentin.
  • Figure 3B shows an energy dispersive x-ray image (elemental maps, Ti Ka1 20KV) of the same block.
  • Composite particle active surprisingly is shown adhering to the dentin block.
  • Figure 4A shows a scanning electron microscopy image of the dentin block after 14 treatments and Figure 4B shows an energy dispersive x-ray image of the same block having received the fourteen treatments.
  • the results unexpectedly demonstrate excellent adhesion of the composite particle active to the dentin surface.
  • Simulated oral care fluid was made by combining the following:
  • FIG. 5 shows scanning electron microscopy images of teeth treated with conventional silica comprising toothpaste (5A) and calcium silicate coated silica (composite particle active) (5B) consistent with this invention.
  • a slurry of 10 weight % titanium dioxide and water was prepared by stirring under atmospheric conditions. The slurry was heated to about 90°C for 30 to 35 minutes. A 1 M sodium silicate solution was added to the heated slurry
  • Figure 6 shows Transmission Electron Microscopy Images of uncoated titanium dioxide 6a and 6b and calcium silicate coated titanium dioxide made consistent with this invention (6c and 6d).
  • the second component coating was homogeneous in that all of the titanium dioxide core was coated and the calcium silicate coating was about 10 nm thick.
  • a composite particle active similar to the one described in Example 4 was made except that zinc oxide was used in lieu of titanium dioxide.
  • Example 1 To investigate the whitening effect of the illustrative dual phase oral care composition of Example 1 , the following consumer study was performed.
  • Group B subjects were given the dual phase oral care composition of Example 1 and consistent with this invention;
  • Group A subjects were given a dual phase composition similar to the one described in Example 1 except that 30% by weight calcium silicate was used and no composite particle active was employed.
  • Group C (the control group) subjects brushed teeth with commercially available toothpaste compositions deplete of active associated with tooth remineralization. Changes in the whiteness between pre- and post- treatment (after 2 weeks and 4 weeks brushing) were obtained using the aforementioned VITA shade tooth guide 3D-Master from Vita Zahnfabrik.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Physics & Mathematics (AREA)
  • Geometry (AREA)

Abstract

Composite particle actives suitable for use in oral care compositions are described. The composite particle actives have a core and a coating whereby the coating interacts with phosphate ions to produce calcium and phosphate reaction products that are suitable to adhere to tooth enamel and/or dentin in order to improve characteristics of teeth.

Description

COMPOSITE PARTICLE ACTIVE AND METHOD
FOR MAKING THE SAME FIELD OF THE INVENTION
The present invention is directed to a composite particle active and method for making the composite particle. More particularly, the invention is directed to composite particle active suitable for use in the mouth to, at the very least, aid in the remineralization and whitening of teeth by interacting with phosphate ions and delivering calcium and phosphate sources to the teeth of consumers. The particles, therefore, are suitable for use in compositions that are used in the mouth. Such particles can, for example, be used in a toothpaste or gel composition, mouthwash, as well as chewing gum compositions. Moreover, the composite particle active of this invention comprises a first component core suitable to immediately improve an oral care characteristic and a second component coating that is suitable to interact with phosphate ions to produce calcium and phosphate in situ reaction products that surprisingly adhere well to teeth to provide immediate and long term benefits.
BACKGROUND OF THE INVENTION
Many products we consume have a negative impact on our teeth and mouth. Acidic drinks and sweets, for example, can result in tooth erosion by attacking enamel that coats and protects the teeth. Such an attack on enamel often, and undesirably, causes hypersensitivity of the teeth. Moreover, foods and beverages we consume, like tomato sauce, berries, beets, soda or pop, coffee and tea can stain teeth and thereby result in a smile that is not bright and white. Tobacco based products and certain medications can also lead to teeth that look yellow or even brown. Of course, teeth that are not healthy can lead to bad breath and the growth of unwanted bacteria in the mouth. Products that address tooth decay and/or whitening have been developed. Such products often comprise peroxides, abrasives or both in order to clean and whiten teeth. These types of products are often not desired since they do not contribute to the remineralization of teeth and can cause damage to teeth and gums if overused. Products comprising calcium sources have been developed in an attempt to enhance the characteristics of teeth. Such products, however, do not positively adhere to teeth and thereby may only contact teeth for a brief period prior to being rinsed out of the mouth in wash water.
It is of increasing interest to develop products that provide immediate and long term benefits to teeth. Moreover, it is of increasing interest to develop composite particle actives that can benefit teeth when supplied from a multitude of formats, like toothpaste or gel compositions, mouthwashes as well as chewing gum compositions. This invention, therefore, is directed to composite particle actives that are suitable to deliver calcium and phosphate sources to teeth for a long enough period of time to ensure excellent whitening results. The invention is also directed to a method for making the same. The composite particle actives of the present invention comprises a first component core for immediately improving an oral care characteristic and a second component coating that is suitable to interact with phosphate ions to produce calcium and phosphate in situ reaction products that surprisingly adhere well to teeth for both immediate and long term benefits.
ADDITIONAL INFORMATION
Efforts have been disclosed for making oral care products. In WO
2008/068149 A1 and WO 2008/068248 A1 , oral care products with calcium and phosphate are described.
Other efforts have been disclosed for making oral care products. In U.S. Patent Nos. 4,083,955, 5,605,675 and 6,214,321 B1 , processes and compositions for remineralizing dental enamel are described.
Still other efforts have been disclosed for making oral care products. In U.S. Patent Nos. 6,365,132 B1 and 5,735,942, compositions for use on teeth are described.
In U.S. Patent Application Nos. 2002/0064504 A1 and 2009/0264291 A1 , additional efforts have been disclosed for making oral care compositions. The former describes dental anti-hypersensitivity compositions and the latter describes compositions and methods for preventing or reducing plaque and/or gingivitis using a dentifrice with a bioactive glass.
None of the additional information above describes a composite particle active comprising a core and coating as described herein. Moreover, none of the additional information describes a method for making such a particle as described herein. SUMMARY OF THE INVENTION
In a first aspect, the present invention is directed to a composite particle active comprising:
(a) a first component core for improving an oral care characteristic; and
(b) a second component coating that interacts with phosphate ions to produce a calcium and phosphate in situ reaction product that adheres to tooth enamel, dentin or both and that is a precursor for hydroxyapatite formation. In a second aspect, the present invention is directed to a method for making the composite particle active of the first aspect of this invention.
All other aspects of the present invention will more readily become apparent upon considering the detailed description and examples which follow.
Soluble and insoluble, as used herein, refers to the solubility of a source (e.g., like calcium) in water. Soluble means a source that dissolves in water to give a solution with a concentration of at least 0.1 moles per liter at room temperature. Insoluble means a source that dissolves in water to give a solution with a concentration of less than 0.001 moles per liter at room temperature.
Slightly soluble, therefore, is defined to mean a source that dissolves in water to give a solution with a concentration of greater than 0.001 moles per liter at room temperature and less than 0.1 moles per liter at room temperature. Oral care composition means a composition suitable for use in the mouth and for veterinary and/or human applications but especially for use in applications for the human mouth. Benefitting teeth means at the very least whitening, remineralization or desensitizing teeth or decreasing bacteria within the mouth where the decreasing of bacteria can be the result of employing an antimicrobial agent and the desensitizing of teeth is the result of composite particle active interacting with phosphate ions found in the mouth and/or within the oral care composition and adhering to the teeth to, for example, yield new hydroxyapatite formation on dentinal tubules. Diameter is meant to mean the longest distance measurable in the event the composite particle active is not a perfect sphere. Remineralization, as used herein, means the in situ generation of hydroxyapatite on teeth to reduce the likelihood of tooth decay and improve the appearance of teeth by whitening through the generation of such new hydroxyapatite. Such remineralization also results in whitening of teeth, all of which can include results from the adhering of composite particle active to the teeth and/or the formation of amorphous calcium phosphate on teeth. Single-phase composition means a one phase composition having both calcium and phosphate sources therein and prior to dispensing or unpackaging and use. Anhydrous, as used herein, means substantially free of water (e.g., no water to less than 5% by weight water and preferably less than 1 % by weight water). Dual-phase product means having required and complementary calcium and phosphate hydroxyapatite precursors in separate compositions and stored in separate compartments. Composition as used herein includes, for example, paste, powder, gel, liquid (like mouthwash), spray, foam, balm, a composition carried on a mouthstrip or a buccal adhesive patch, chewable tablet (or pastille), lozenge, cream, beverage or a strip of gum. Preferably, however, the composition is a paste like toothpaste or a gel for teeth. Carrier, as used herein, means a component in the composition other than the composite particle active and phosphate source whereby the carrier is suitable to deliver the active and any phosphate source present therein. First component core, as used herein, is meant to include the portion of the composite particle active that is coated whereby the core can comprise particle or an aggregate of particle like, for example, an agglomerate of ΤΊΟ2. Core is also meant to include a component that provides immediate (e.g., within three (3) uses of the composition, but preferably, within 1 second to 5 minutes of using) whitening benefits to teeth via physical mechanisms. Long term benefit is meant to include a benefit that will last at least for weeks, but preferably, at least four (4) months. In general, the core is meant to be a component that may improve a characteristic of teeth. Second component coating, as used herein, means a coating that forms an external coat or clad on at least a portion of the first component core. Not to be bound by theory, adhering, as used herein, can include effectively depositing and/or bonding or "sticking" to teeth as a result of calcium in the coating of the composite particle active and phosphate ion interactions. Coating is also meant to include a component that provides benefits to teeth over time through biological or chemical mechanisms like the formation of hydroxyapatite. Composite particle active, therefore, is meant to mean a particle that may provide both immediate and long term benefits to teeth after use. In situ reaction product means a product comprising calcium and phosphate generated in the mouth. All ranges defined herein are meant to include all ranges subsumed therein unless specifically stated otherwise. Comprising, as used herein, is meant to include consisting essentially of and consisting of, and should be understood to not preclude the inclusion of other components. BRIEF DESCRIPTION OF THE DRAWINGS
The subject matter which is regarded as the invention is particularly pointed out and distinctly claimed in the concluding portion of the specification. The invention, however, may be best understood by reference to the following description taken in conjunction with the accompanying drawing figures in which:
Figure 1 (A and B) shows composite particle active adhesion to enamel after one treatment.
Figure 2 (A and B) shows composite particle active adhesion to enamel after fourteen treatments.
Figure 3 shows composite particle active adhesion to dentin after one treatment.
Figure 4 shows composite particle active adhesion to dentin after fourteen treatments.
Figure (A and B) shows conventional silicone and composition particle active deposition on the surface of teeth; Figure 6 (a-d) shows Transmission Election Microscopy Images of uncoated and coated titanium dioxide particles; and
Figure 7 shows results from a consumer tooth whitening study after 2 weeks and 4 weeks treatment as compared to baseline.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
The only limitation with respect to the composite particle active that may be used in this invention is that the same is suitable for use in the mouth. Typically, the core of the composite particle active comprises a material suitable to physically and immediately improve characteristics of teeth, and especially, whiten teeth. Such a material typically has an index of refraction from 1 .2 to 3, preferably, from 1 .3 to 2.8, and most preferably, from 1 .5 to 2.8, including all ranges subsumed therein. Illustrative yet non-limiting examples of such core materials that are suitable to physically improve teeth include silica, titanium dioxide, zinc oxide, mica (including coated mica like commercially available iron oxide coated mica), calcium carbonate, barium sulfate or a mixture thereof. The core of the composite particle active typically makes up from 3 to 98%, and preferably, from 6 to 65%, and most preferably, from 10 to 55% by weight of the composite particle active, based on total weight of the composite particle active and including all ranges subsumed therein. In an especially preferred
embodiment, the core is at least 50% by weight titanium dioxide or zinc oxide, and most preferably, from 60 to 100% by weight titanium dioxide or zinc oxide, based on total weight of the first component core.
The coating suitable to adhere to tooth enamel, dentin or both typically comprises a metal element such as calcium, and optionally, other metals like potassium, sodium, aluminum, magnesium, as well as mixtures thereof. In a preferred embodiment, the same is suitable to provide a biological or chemical improvement to teeth which is both long and short term (e.g., results in whitening and hydroxyapatite formation). Preferably, the coating employed comprises at least 50% by weight elemental calcium, and most preferably, at least 65% by weight elemental calcium based on total weight of metal in the coating. In an especially preferred embodiment, the metal element in the coating is from 80 to 100% by weight elemental calcium, based on total weight of metal in the second component coating and including all ranges subsumed therein. In another especially preferred embodiment, the core and the coating are slightly soluble or insoluble in water, but most preferably, insoluble in water.
Usually, at least 5% of the outer surface of the core is coated with coating, and preferably, at least 50% of the core is covered with coating. In a most preferred embodiment, 70 to 100% of the outer surface area of the first component core is coated with the second component coating.
The diameter of the composite particle active is often from 10 nm to less than 50 microns, and preferably, from 75 nm to less than 10 microns. In an especially preferred embodiment, the diameter of composite particle active is from 500 nm to 5 microns, including all ranges subsumed therein. In yet another especially preferred embodiment, at least 40%, and preferably, at least 60%, and most preferably, from 75 to 99.5% of the diameter of the composite particle active is the result of core, including all ranges subsumed therein.
An oral care composition suitable to carry the composite particle active of this invention usually comprises from 0.25 to 40%, and preferably, from 0.5 to 20%, and most preferably, from 0.5 to 15% by weight composite particle active, based on total weight of the oral care composition and including all ranges subsumed therein. In an especially preferred embodiment, the composition comprises an overall metal (e.g., calcium ion) content of less than 40%, and preferably, less than 30%, and most preferably, from 1 to 25% by weight metal element, based on total weight of the composition and including all ranges subsumed therein. In still another especially preferred embodiment, composite particle active may be added to a composition along with an additional metal source like a calcium source. Such an additional metal source may be identical to that which is used to coat the core of the composite particle active (e.g., calcium silicate or calcium oxide). When added, the additional metal source typically makes up from 0.1 to 35%, and preferably, from 1 to 25%, and most preferably, from 10 to 20% by weight of the total weight of the oral care composition and including all ranges subsumed therein. In an especially desired embodiment, the second component coating can comprise, for example, calcium phosphate, calcium gluconate, calcium oxide, calcium lactate, calcium carbonate, calcium hydroxide, calcium sulfate, calcium carboxymethyl cellulose, calcium alginate, calcium salts of citric acid, calcium silicate, mixtures thereof or the like. In another desired embodiment, the calcium source in the coating will comprise calcium silicate. These compounds are also suitable to include as reagents for calcium sources when making the composite particle active of this invention. Similar salts with sodium, magnesium, aluminum and potassium in lieu of calcium may, for example, be used as reagents to provide the anionic portion of the second component coating during particle
manufacturing.
In yet another preferred embodiment, the coating can comprise a calcium source which is insoluble calcium silicate, present as the composite material calcium oxide-silica (CaO-SiO2) as described in commonly-owned applications, World Application Nos. 2008/0151 17 and 2008/068248.
When a calcium silicate composite material is employed as coating, the ratio of calcium to silicon (Ca:Si) may be from 1 : 10 to 3:1 . The Ca:Si ratio is preferably from 1 :5 to 2:1 , and more preferably, from 1 :3 to 2:1 , and most preferably, from about 1 :2 to 2:1 . The calcium silicate may comprise mono- calcium silicate, bi-calcium silicate, or tri-calcium silicate whereby ratios of calcium to silicon (Ca:Si) should be understood to be atom ratios.
The preferred calcium source employed in this invention to generate second component coating on the composite particle active may be in a crystalline or amorphous state. In an often preferred embodiment, the calcium source for coating is in a mesoporous state, i.e. the source is a material having pores with diameters from 1 nm to 1 micron. Mesoporous calcium silicate (MCS) is often preferred.
The MCS which may be used in second component coating in this invention can be made by combining a calcium salt (e.g., calcium chloride, calcium carbonate, calcium hydroxide), a silica precursor like silicate (e.g., sodium silicate, potassium silicate, tetraethyl orthosilicate or tetraethylsilicate) and a structure-directing agent to yield a solid suitable for calcinating. A more detailed description of the process that may be conducted to make the MCS suitable for use in this invention is described in the aforementioned commonly-owned application, Publication No. WO 2008/0151 17. In an often desired embodiment, coating may be formed from CaO-SiO2.
In still another often preferred embodiment, oral care compositions comprising the composite particle active of this invention further comprise a phosphate source. The phosphate source that may be used in this invention is limited only to the extent that the same may be used in a composition suitable for use in the mouth. Illustrative examples of the types of phosphate source suitable for use in this invention and added along with the composite particle actives described include monosodium phosphate, sodium dihydrogen phosphate, disodium hydrogen phosphate, sodium pyrophosphate, tetrasodium
pyrophosphate, sodium tripolyphosphate, sodium hexametaphosphate, potassium dihydrogenphosphate, trisodium phosphate, tripotassium phosphate, mixtures thereof or the like. The phosphate source is preferably one which is water soluble.
When used, the phosphate source typically makes up from 0.5 to 22%, and preferably, from 2 to 18%, and most preferably, from 4 to 16% by weight of the oral care composition, based on total weight of the oral care composition and including all ranges subsumed therein. In a preferred embodiment, the phosphate source used is one which results in an oral care composition (i.e., combined composition if a dual phase product) having a pH from 5.5 to 8, preferably from 6 to 7.5, and most preferably, about neutral. In a most preferred embodiment, the phosphate source used is trisodium phosphate and monosodium dihydrogen phosphate at a trisodium phosphate to monosodium dihydrogen phosphate weight ratio of 1 :4 to 4:1 , preferably 1 :3 to 3:1 , and most preferably, from 1 :2 to 2:1 , including all ratios subsumed therein.
Oral care compositions for benefitting teeth and comprising the composite particle active of this invention may comprise optional ingredients which are common in the art. These ingredients include: ■ antimicrobial agents, e.g. Triclosan, chlorhexidine, copper-, zinc- and stannous salts such as zinc citrate, zinc sulphate, zinc glycinate, sodium zinc citrate and stannous pyrophosphate, sanguinarine extract, metronidazole, quaternary ammonium compounds, such as cetylpyridinium chloride; bis-guanides, such as chlorhexidine digluconate, hexetidine, octenidine, alexidine; and halogenated bisphenolic compounds such as 2,2' methylenebis-(4-chloro-6- bromophenol); anti-inflammatory agents such as ibuprofen, flurbiprofen, aspirin, indomethacin, etc.; anti-caries agents such as sodium trimetaphosphate and casein;
plaque buffers such as urea, calcium lactate, calcium
glycerophosphate and strontium polyacrylates;
vitamins such as Vitamins A, C and E;
plant extracts;
desensitizing agents, e.g. potassium citrate, potassium chloride, potassium tartrate, potassium bicarbonate, potassium oxalate, and potassium nitrate;
anti-calculus agents, e.g. alkali-metal pyrophosphates,
hypophosphite-containing polymers, organic phosphonates and phosphocitrates, etc.;
biomolecules, e.g. bacteriocins, antibodies, enzymes, etc.
flavors, e.g., peppermint and spearmint oils;
proteinaceous materials such as collagen;
preservatives;
opacifying agents;
colouring agents like FD&C blue, yellow and/or red dyes/colorants;
pH-adjusting agents; sweetening agents; surfactants, such as anionic, nonionic, cationic and zwitterionic or amphoteric surfactants (e.g., sodium lauryl sulfate, sodium dodecylbenzene sulfonate); particulate abrasive materials such as abrasive silicas, aluminas, calcium carbonates, zirconium silicate, polymethylmethacrylate, dicalciumphosphates, calcium pyrophosphates, hydroxyapatites, trimetaphosphates, insoluble hexametaphosphates as well as agglomerated particulate abrasive materials; fluoride sources like sodium fluoride, stannous fluoride, sodium monofluorophosphate, zinc ammonium fluoride, tin ammonium fluoride, calcium fluoride, cobalt ammonium fluoride or mixtures thereof; polymeric compounds which can enhance the delivery of active ingredients such as antimicrobial agents can also be included. Examples of such polymers are copolymers of polyvinylmethylether with maleic anhydride and other similar delivery enhancing polymers, e.g., those described in DE-A03,942,643; buffers and salts to buffer the pH and ionic strength of the oral care compositions; and other optional ingredients that may be included are, e.g., bleaching agents such as peroxy compounds, e.g., potassium
peroxydiphosphate, effervescing systems such as sodium
bicarbonate/citric acid systems, color change systems, and the like. Such ingredients typically and collectively make-up less than 20% by weight of the oral care composition comprising the composite particle active of this invention, and preferably, from 0.0 to 15% by weight, and most preferably, from 0.01 to 12% by weight of the oral care composition, including all ranges subsumed therein.
Thickener may also be used in this invention and is limited only to the extent that the same may be added to a composition suitable for use in the mouth along with the composite particle actives of this invention. Illustrative examples of the types of thickeners that may be used in this invention include, sodium carboxymethyl cellulose, hydroxyl ethyl cellulose, methyl cellulose, ethyl cellulose, gum tragacanth, gum Arabic, gum karaya, sodium alginate, carrageenan, guar, xanthan gum, Irish moss, starch, modified starch, silica based thickeners including silica aerogels, magnesium aluminum silicate (i.e., Veegum) Carbomers (cross- linked acrylates) and mixtures thereof.
Typically, sodium carboxymethyl cellulose and/or a Carbomer is/are preferred. When a Carbomer is employed, those having a molecular weight of at least 700,000 are desired, and preferably, those having a molecular weight of at least 1 ,200,000, and most preferably, those having a molecular weight of at least about 2,500,000 are desired. Mixtures of Carbomers may also be used herein.
In an especially preferred embodiment, the Carbomer is Carbopol® 980. It has been described as a high molecular weight and cross-linked polyacrylic acid and identified via CAS number 9063-87-0. The same is available commercially from Lubrizol Advanced Materials, Inc.
In another especially preferred embodiment, the sodium carboxymethyl cellulose (SCMC) used is SCMC 9H. It has been described as a sodium salt of a cellulose derivative with carboxymethyl groups bound to hydroxy groups of glucopyranose backbone monomers and identified via CAS number 9004-32-4. The same is available from suppliers like Alfa Chem.
Thickener typically makes up from 0.01 to about 10%, and preferably, from 0.1 to 8%, and most preferably, from 1 .5 to 6% by weight of the oral care composition, based on total weight of the oral care composition and including all ranges subsumed therein.
Suitable carriers that may be employed in this invention are, for example, glycerin, sorbitol, propylene glycol, dipropylene glycol, diglycerol, triacetin, mineral oil, polyethylene glycol (preferably, PEG-400), alkane diols like butane diol and hexanediol, ethanol, pentylene glycol, or a mixture thereof. The carriers should, in any case, be substantially free of water, and preferably, anhydrous if a single phase product comprising phosphate as an additive and composite particle active are desired. The carrier can, for example, be used in solid form, but glycerin is often the preferred carrier or humectant in single phase products.
The carrier is used to take the balance of the single phase compositions up to 100%, and the same may be present in the range from 10 to 90% by weight of the single phase oral care composition. Preferably, carrier makes up from 25 to 80%, and most preferably, from 45 to 70% by weight of the single phase oral care composition, based on total weight of the single phase oral care composition and including all ranges subsumed therein. In the event an aqueous oral care product with a phosphate source is desired, a dual phase oral care composition is recommended to prevent interaction (prior to use) between the phosphate and second component coating of the composite particle active. When a dual phase oral care composition is desired, water may act as a carrier (along with thickeners and/or additional carriers herein described) and make up the balance of each composition in the dual phase product wherein a first composition will comprise composite particle active and a second composition will comprise the added phosphate source. Within the dual phase product, the first and second compositions should not come into contact with each other until dispensed for use by the consumer in his or her mouth. When a dual phase oral care composition is used, the weight percents described herein are meant to characterize the oral care composition after the first and second compositions have been combined. The delivery of each composition (in the event a dual composition product is desired) may be sequential or simultaneous, but preferably, simultaneous. In a preferred embodiment, each composition within the dual phase oral care composition comprises less than 35% by weight water, and most preferably, from 15 to 25% by weight water, based on total weight of each composition and including all ranges subsumed therein. One or preferably both of the compositions within the dual phase oral care composition may be applied to the teeth, with treatment of the teeth involving mixing of the compositions. Whether single or dual phase, the compositions are preferably left on the teeth following application. Following such application, the oral care compositions of this invention should typically be left on the teeth for 5 seconds to 10 hours and more typically from 35 seconds to 30 minutes. The application may be carried out daily. If a dual composition is employed, the same may be applied from independent compartments at a dual compartment tube or from independent phases of a product contained within a single container which is typically a tube.
In certain embodiments, in particular those involving a gel composition, the means of delivery may optionally involve a tape, in particular an adhesive tape strip, onto which the compositions of this invention are applied prior to the strip being placed in contact with the teeth. When using such a means of delivery, the compositions can be held in close contact with the surface of the teeth, facilitating a high concentration of composite particle active and phosphate close to the surface of the teeth.
When a gel is desired, the same typically comprises a polymeric matrix, and is more typically a hydrogel. Excluding any water present, the polymeric matrix is typically present at from 1 to 25% by weight of the composition of which it is a part.
Monomers used to prepare hydrogels may be selected from, for example, vinyl alcohol and acrylate, in particular sodium acrylate. Other monomers comprising an abundance of hydrophilic groups may also be used.
Often preferred hydrogels comprise a polysaccharide, polyacrylamide, polyacrylic acid, or a mixture thereof.
Suitable polysaccharides may be storage polysaccharides, such as starch or glycogen, or structural polysaccharides, such as cellulose or chitin.
Illustrative polysaccharides which may be used include those having saccharide units selected from one or more of the following: isomaltose, glucose, fructose, galactose, xylose, mannose, sorbose, arabinose, rhamnose, fucose, maltose, sucrose, lactose, maltulose, ribose, lyxose, allose, altrose, gulose, idose, talose, trehalose, nigerose, kojibiose, and lactulose. Often preferred hydrogels comprise at least one polysaccharide selected from the group consisting of: tamarind gum, guar gum, locust bean gum, Tara, Fenugreek, Aloe, Chia, Flaxseed, Psyllium seed, quince seed, xanthan, gellan, welan, rhamsan, dextran, curdlan, pullulan, scleroglucan, schizophyllan, chitin, hydroxyalkyl cellulose, arabinan, de-branched arabinan, arabinoxylan, glactan, pectic galactan, galactomannan, glucomannan, lichenan, mannan, pachyman, rhamnogalacturonan, acacia gum, agar, alginates, carrageenan, chitosan, clavan, hyaluronic acid, heparin, inulin, cellodextrins, cellulose, and cellulose derivatives.
Especially preferred hydrogels can comprise polysaccharides like those selected from the group consisting of: sodium alginate, hydroxypropyl alginate, gum carrageenan, gum arabic, guar gum, karaya gum, chitosan and pectin.
Compositions comprising the composite particle actives of this invention (whether single or dual phase) are prepared by conventional methods of making oral care compositions. Such methods include mixing the ingredients under moderate shear and atmospheric pressure. The compositions are desired for use in the mouth, and preferably, are of the form that may be brushed onto teeth with a toothbrush. Unexpectedly, the oral care compositions of this invention result in excellent remineralization of teeth (i.e., new hydroxyapatite formation) and teeth whitening (which may be immediate and provided for by the core of the composite particle active) as a result of composite particle active adhering to enamel and/or dentin of teeth. Moreover, subsequent to using the compositions of this invention, teeth are unexpectedly less sensitive, and shinier, the same also being a direct result of composite particle active adhering to the enamel and/or dentin of teeth.
The composite particle active of this invention may be prepared by creating a slurry comprising core material and solvent (e.g., low molecular weight ketones like acetone, low molecular weight alcohols like C3-6 alkanols, water or mixtures thereof), the slurry comprising 3 to 60%, and preferably, 5 to 30%, and most preferably, 5 to 20% by weight core material based on total weight of the slurry.
Water is typically the preferred solvent. The core material (like titanium oxide or mica) slurry should be heated from 25 to 95°C, and preferably, from 55 to 95°C, and most preferably, from 70 to 90°C, including all ranges subsumed therein. While heating, precursor for anionic portion of coating (like sodium silicate or silica) should then be added to the heated slurry to provide for coating on core material. The curing of the anionic portion (i.e., anionic precursor portion) within the slurry should last from 0.5 hours to 3 hours, and preferably, from 0.5 hours to 1 hour at an alkaline pH (preferably 8.5 to pH 1 1 , and most preferably, 9 to pH 10.5). Further but preferred curing of the slurry can be achieved under acidic conditions (i.e., preferably 3 to pH 5), for an additional 0.5 to 2 hours when the core material is not soluble in the slurry under such acidic conditions. Subsequent to curing the anionic portion of coating, chemical metal material suitable to supply cations, like calcium ions, should then be added to the resulting cured core slurry. The resulting mixture with cations should be cured from 0.5 hours to 24 hours, and preferably, from 0.5 hours to 2 hours at a pH from 9 to 13 and at
temperatures within the ranges for curing core. In an often preferred step, anionic precursor reagents like sodium alginate and/or sodium sulfate can further be added for in situ generation of coating material within the slurry. Slurry pH may be adjusted with conventional ingredients like NaOH or HCL. Mixing of ingredients may be achieved with conventional mixing apparatus. Often, however, a pipeline reactor having a zone of turbulence is often preferred. Conventional catalysts or structure directing agents may be used to generate composite particle. These agents typically make up from 0.01 to 3% by weight of the slurry when they are used. An often preferred agent is a cetyltrialkyl ammonium halide like
cetyltrimethyl ammonium bromide and the like. In an especially preferred embodiment, silica is used in the core material and solvent slurry for coating manufacture. The resulting particles may be cleaned by conventional techniques which include filtration and/or centrifugation and subsequently dried. The desired composite particles of this invention may be recovered by drying such resulting particles where drying may be accelerated with heat and usually takes about 10 minutes to two (2) hours when heating to a temperature in the range from 65°C to 1000°C.
When the oral care composition of this invention is a toothpaste or gel, the same typically has a viscosity from about 50,000 to 180,000 centipoise, and preferably, from 60,000 to 170,000 centipoise, and most preferably, from 65,000 to 165,000 centipoise, taken at room temperature with a Brookfield Viscometer, Spindle No. 4.
In toothpaste or gel form, the composition may be packaged in a
conventional plastic laminate, metal tube or a single compartment dispenser. The same may be applied to dental surfaces by any physical means, such as a toothbrush, fingertip or by an applicator directly to the sensitive area. Solid dosage form types include pastilles, lozenges, chewing gums, tablets,
mouthstrips, balms, and the like. These may be contained in conventional packaging desirable for consumer use.
The following examples are provided to facilitate an understanding of the present invention. The examples are not provided to limit the scope of the claims. Example 1
A dual phase aqueous-based oral care composition for benefitting teeth and consistent with this invention (i.e., comprising composite particle active) was made by mixing the ingredients below under conditions of moderate shear, atmospheric pressure and ambient temperature. The compositions made were suitable for use with a toothbrush, and when combined about equally were not gritty and resulted in an excellent ribbon when applied to a toothbrush. The combined compositions, which resulted in the oral care composition of this invention, had consumer acceptable taste characteristics. Calcium Comprising Phase:
Ingredients Percent by Weight
Sorbitol (70%) 20.0
Water balance
Preservative 1 .0
Sodium monofluorophosphate 1 .1
Sweetener (artificial) 0.2
Calcium silicate* 20.0
Abrasive silica 6.0
Thickening silica (fumed silica) 2.5
Calcium silicate coated titanium 4.00 dioxide**
Flavor 0.9
Sodium carboxymethyl cellulose 0.6
Sodium lauryl sulphate (30%) 6.60 as supplied by Ineos Silicas, Ltd.
composite particle active, coating ~ 10 nm; particle diameter ~ 100 to 300 nm
Phosphate Comprising Phase:
Ingredients Percent by Weight
Sorbitol (70%) 55.0
Trisodium phosphate 7.6
Water Balance
Polyethylene glycol (1500) 2.0
Sodium monofluorophosphate 1 .1
Sweetener (artificial) 0.27
Color 0.002
Abrasive silica 12.0
Monosodium phosphate 6.4
Thickening silica (fumed silica) 3.5
Sodium lauryl sulphate 30% 6.6
Flavour 1 .2
Sodium carboxymethyl cellulose 0.5 Example 2
Enamel and dentin blocks (3 cm2) were polished for at about 5 minutes using silicone carbide abrasive paper (1200 grit). The dentin blocks were acid etched for 60 seconds using 36% phosphoric acid, followed by a water wash. The blocks were purchased from a commercial supplier.
A slurry comprising 20% by weight calcium silicate and 4% by weight composite particle active (similar to the one described in Example 1 ) were added to a water balance to make a slurry. A sodium phosphate slurry was made by adding 20% by weight sodium phosphate to a water balance. The resulting slurries were homogenized for about 10 minutes using conventional stirring apparatus in order to yield homogeneous compositions.
The homogenized slurries were poured into petri dishes. Enough was used to cover the surface of the blocks which were placed in the dishes. The blocks were brushed with a toothbrush for 1 minute and incubated in the slurry for one minute. The blocks were subsequently washed with distilled water three times and further incubated in simulated oral cavity fluid for at about 2 hours in a 37°C water bath. Treatment for each block was repeated 14 times.
Results of Treatment - Enamel Blocks Figure 1A shows a scanning electron microscopy image of the enamel block after one treatment. Composite particle active (circled) surprisingly is shown adhering to the surface of the enamel block after one treatment.
Figure 1 B shows an energy dispersive x-ray image (elemental maps, Ti Ka1 , 20KV) of the same block. Composite particle active is shown as bright dots (circled) surprisingly adhering well to the enamel block after one treatment. Figure 2A shows a scanning electron microscopy image of the enamel block after 14 treatments and Figure 2B shows an energy dispersive x-ray image of the same block having received fourteen treatments. The results unexpectedly demonstrate excellent adhesion of the composite particle active to the enamel surface.
Results of Treatment - Dentin Blocks
Figure 3A shows a scanning electron microscopy image of the dentin block after one treatment. Composite particle active surprisingly is shown adhering to the surface of the dentin.
Figure 3B shows an energy dispersive x-ray image (elemental maps, Ti Ka1 20KV) of the same block. Composite particle active surprisingly is shown adhering to the dentin block.
Figure 4A shows a scanning electron microscopy image of the dentin block after 14 treatments and Figure 4B shows an energy dispersive x-ray image of the same block having received the fourteen treatments. The results unexpectedly demonstrate excellent adhesion of the composite particle active to the dentin surface.
The unexpected adhesion of the active compositions of this invention to tooth enamel and dentin inevitably will result in tooth remineralization,
desensitizing and shine.
Example 3
To investigate the whitening effect of the illustrative dual phase oral care composition of Example 1 , the following in vitro test was performed. Human teeth were cleaned and separated into two groups (N=8). While treating, the composition of Example 1 was applied to the surface of teeth (Group I) with cotton buds. After 30 minutes, the treated teeth were brushed with a slurry of commercially available toothpaste and water (e.g., fluoride comprising toothpaste, 1 % sodium fluoride : water = 1 :2) for one (1 ) minute to clean the treated surface. The cleaned teeth were incubated in simulated oral fluid for about 2 hours. The teeth were subject to 14 cycles of the above treatment.
Simulated oral care fluid was made by combining the following:
Simulated Oral Fluid
Figure imgf000025_0001
The treatments to the teeth of Group II were the same as that for Group I except that only the commercially available toothpaste was used.
Changes in the whiteness between pre- and post-treatment were obtained using a Konica Minolta - 2600D colour analyzer. The results, unexpectedly demonstrate that teeth treated with the composition of this invention had an excellent whitening index of about 4.80 whereby conventionally available product had a whitening index of only about -0.91 . Moreover, Figure 5 shows scanning electron microscopy images of teeth treated with conventional silica comprising toothpaste (5A) and calcium silicate coated silica (composite particle active) (5B) consistent with this invention.
Surprisingly, as may be observed in the images, significantly more particles (especially particles/agglomerates at circa 2 μιτι diameter in size) deposited on the surface of teeth when made consistent with this invention.
Example 4
A slurry of 10 weight % titanium dioxide and water was prepared by stirring under atmospheric conditions. The slurry was heated to about 90°C for 30 to 35 minutes. A 1 M sodium silicate solution was added to the heated slurry
(S1O2/T1O2, 10 weight %). Hydrochloric acid (0.5 M) was added to buffer the pH of the slurry from 9 to 10.5 for a one (1 ) hour period. Heat was removed so that the resulting slurry was cooled to around 70°C. To the cooled slurry was added a 1 M CaCI2 solution (CaCI2/SiO2, 1 M, 1 M). A 1 M sodium hydroxide solution was also added to the resulting slurry to buffer pH in the range of 10.5 to 12 for a one (1 ) hour period. The resulting slurry was cleaned via centrifugation and dried at 90°C for about 45 minutes. The resulting particles were composite particle actives consistent with this invention.
Figure 6 shows Transmission Electron Microscopy Images of uncoated titanium dioxide 6a and 6b and calcium silicate coated titanium dioxide made consistent with this invention (6c and 6d). The second component coating was homogeneous in that all of the titanium dioxide core was coated and the calcium silicate coating was about 10 nm thick. Example 5
A composite particle active similar to the one described in Example 4 was made except that zinc oxide was used in lieu of titanium dioxide. Transmission Electron Microscopy Images revealed the successful calcium silicate coating of zinc oxide core when performing the method of this invention.
Example 6
To investigate the whitening effect of the illustrative dual phase oral care composition of Example 1 , the following consumer study was performed.
Selected subjects, having an initial teeth color range higher than 3M1 as determined by the tooth guide 3D-Master from Vita Zahnfabrik, were divided into about three equal groups, (N=55) and groups A, B and C. All subjects were asked to brush their teeth twice a day. Each group was given a different toothpaste. Group B subjects were given the dual phase oral care composition of Example 1 and consistent with this invention; Group A subjects were given a dual phase composition similar to the one described in Example 1 except that 30% by weight calcium silicate was used and no composite particle active was employed. Group C (the control group) subjects brushed teeth with commercially available toothpaste compositions deplete of active associated with tooth remineralization. Changes in the whiteness between pre- and post- treatment (after 2 weeks and 4 weeks brushing) were obtained using the aforementioned VITA shade tooth guide 3D-Master from Vita Zahnfabrik.
The results presented in Figure 7, unexpectedly, demonstrate that the teeth of subjects in Group B obtained a significant decrease in VITA value after 4 weeks treatment, and a detectable decrease after only 2 weeks of treatment. Teeth from subjects in Group A obtained a decrease in VITA value but the decrease was essentially not detectable prior to 4 weeks of treatment. The teeth of subjects from control Group C displayed no significant change in VITA value after 4 weeks treatment.
The results demonstrate significant reduction in VITA values for teeth of subjects using compositions made consistent with this invention whereby the whitening effect to teeth of subjects using an oral care composition consistent with this invention were, surprisingly, significantly better when compared to teeth treated with compositions deplete of composite particle active. Figure 7 shows the change in VITA values from a baseline after 2 weeks and 4 weeks for the groups tested. The unexpected and superior whitening results obtained when using oral care compositions consistent with this invention is shown for Group B.

Claims

CLAIMS:
1 . A composite particle active comprising:
a) a first component core for improving an oral care characteristic; and b) a second component coating that interacts with phosphate ions to produce a calcium phosphate in situ reaction product that adheres to tooth enamel, dentin or both and that is a precursor for hydroxyapatite formation.
2. The composite particle active according to claim 1 wherein the first component core comprises silica, titanium dioxide, zinc oxide, mica, calcium carbonate, barium sulfate, or a mixture thereof, and the second component coating comprises elemental calcium, and optionally, potassium, sodium, aluminum, magnesium or a mixture thereof.
3. The composite particle active according to claim 1 or claim 2 wherein at least 5% of the first component core is coated with second component coating.
4. The composite particle active according to any of the preceding claims wherein the composite particle active has a diameter of less than 50 microns.
5. The composite particle active according to any of the preceding claims wherein the core of the composite particle active makes up from 3 to 98% by weight of the composite particle active.
6. The composite particle active according to any of claims 2 to 5 wherein the first component core comprises at least 50% by weight titanium dioxide and the second component coating comprises at least 50% by weight calcium element.
7. The composite particle active according to any of the preceding claims wherein the second component coating comprises calcium phosphate, calcium gluconate, calcium oxide, calcium lactate, calcium carbonate, calcium hydroxide, calcium sulfate, calcium carboxymethyl cellulose, calcium alginate, calcium salts of citric acid, calcium silicate or a mixture thereof.
8. The composite particle active according to claim 1 wherein the second component coating comprises calcium silicate which is CaSiO3, CaO-SiO2 or a mixture thereof.
9. The composite particle active according to any of the preceding claims wherein the second component coating interacts with phosphate ions and adheres to tooth enamel, dentin or both.
10. The composite particle active according to any of the preceding claims wherein the composite particle active comprises a diameter from 10 nm to less than 10 microns.
1 1 . The composite particle active according to claim 10 wherein at least 40% of the diameter of the composite particle active is the result of core.
12. The composite particle active according to any of the preceding claims wherein at least 70 to 100% of the first component core is coated with second component coating.
13. The composite particle active according to claim 1 wherein the second component coating comprises calcium oxide-silica.
14. The composite particle active according to any of the preceding claims wherein the second component coating comprises calcium silicate having a calcium to silica ratio from 1 : 10 to 3:1 .
15. The composite particle active according to any of the preceding claims wherein the second component coating comprises mesoporous calcium silicate
16. The composite particle active according to any of the preceding claims wherein the composite particle active may be carried in toothpaste, tooth gel, a tablet, chewing gum, cream, a beverage, lozenge, a mouthstrip or a patch.
17. A method for making the composite particle active of claim 1 comprising the steps of:
a) mixing core material with solvent to product a core slurry; b) heating the core slurry from 25°C to 95°C for 0.5 to 3 hours;
c) adding reagent suitable for in situ generation of coating material to produce a core and coating material slurry; and
drying the core and coating material slurry to recover the composite particle active wherein the core slurry is first heated under alkaline conditions and subsequently acidic conditions if the core material is insoluble under acidic conditions.
18. The method according to claim 17 wherein the core material comprises silica, titanium dioxide, zinc oxide, mica, calcium carbonate, barium sulfate, or a mixture thereof.
19. The method according to claim 17 or claim 18 wherein the reagent suitable for in situ generation of coating material comprises silica, sodium silicate, potassium silicate, sodium alginate, sodium sulfate, tetraethyl orthosilicate, or a mixture thereof.
20. The method according to claim 17 or claim 18 wherein the reagent suitable for in situ generation of coating material comprises calcium silicate, calcium phosphate, calcium gluconate, calcium oxide, potassium chloride, calcium lactate, calcium carbonate, calcium hydroxide, calcium sulfate, calcium
carboxymethyl cellulose, Calcium chloride, magnesium chloride, aluminum chloride, calcium alginate, calcium salts of citric acid, mixtures thereof or the like.
PCT/EP2011/053740 2010-09-10 2011-03-11 Composite particle active and method for making the same WO2012031785A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US13/820,154 US20130164359A1 (en) 2010-09-10 2011-03-11 Composite particle active and method for making the same
BR112013004354A BR112013004354B8 (en) 2010-09-10 2011-03-11 composite particle asset and method of producing the composite particle asset
CN2011800433996A CN103079645A (en) 2010-09-10 2011-03-11 Composite particle active and method for making the same
EP11710153.5A EP2613850B1 (en) 2010-09-10 2011-03-11 Composite particle active and method for making the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNPCT/CN2010/001396 2010-09-10
CN2010001396 2010-09-10

Publications (2)

Publication Number Publication Date
WO2012031785A2 true WO2012031785A2 (en) 2012-03-15
WO2012031785A3 WO2012031785A3 (en) 2012-10-18

Family

ID=44625514

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/053740 WO2012031785A2 (en) 2010-09-10 2011-03-11 Composite particle active and method for making the same

Country Status (6)

Country Link
US (1) US20130164359A1 (en)
EP (1) EP2613850B1 (en)
CN (2) CN103079645A (en)
BR (1) BR112013004354B8 (en)
SA (1) SA111320297B1 (en)
WO (1) WO2012031785A2 (en)

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013013275A1 (en) * 2011-07-27 2013-01-31 B Athanassiadis Dental Pty Ltd Alkaline compositions and their dental and medical use
WO2015036277A1 (en) * 2013-09-10 2015-03-19 Unilever N.V. Oral care composition
CN105517633A (en) * 2013-09-10 2016-04-20 荷兰联合利华有限公司 Oral care composition
WO2016180620A1 (en) * 2015-05-13 2016-11-17 Unilever N.V. Oral care composition
WO2016180601A1 (en) 2015-05-13 2016-11-17 Unilever N.V. Oral care composition
WO2016192925A1 (en) 2015-06-05 2016-12-08 Unilever Plc Oral care device
WO2016192924A1 (en) 2015-06-05 2016-12-08 Unilever Plc Oral care device
WO2017050528A1 (en) * 2015-09-24 2017-03-30 Unilever N.V. Oral care composition
WO2017080687A1 (en) 2015-11-10 2017-05-18 Unilever N.V. Oral care composition
US10010491B2 (en) 2013-09-10 2018-07-03 Conopco Inc. Oral care composition
US10064794B2 (en) 2012-12-24 2018-09-04 Colgate-Palmolive Company Oral care composition
WO2018224331A1 (en) * 2017-06-07 2018-12-13 Unilever N.V. Oral care composition
WO2019007695A1 (en) * 2017-07-07 2019-01-10 Unilever N.V. Oral care composition
WO2019029917A1 (en) * 2017-08-10 2019-02-14 Unilever N.V. Oral care composition
US10369091B2 (en) 2013-12-20 2019-08-06 Colgate-Palmolive Company Core shell silica particles and uses thereof as an anti-bacterial agent
WO2020052855A1 (en) 2018-09-12 2020-03-19 Unilever Plc Oral care composition
US10596084B2 (en) 2013-12-20 2020-03-24 Colgate-Palmolive Company Tooth whitening oral care product with core shell silica particles
WO2020212159A1 (en) 2019-04-17 2020-10-22 Unilever Plc Oral care product
EP3865112A1 (en) * 2020-02-13 2021-08-18 Xi'an University of Science and Technology Method for making composition for enamel regeneration
EP3888620A1 (en) 2020-04-02 2021-10-06 Unilever Global IP Ltd Oral care system
EP3888623A1 (en) 2020-04-02 2021-10-06 Unilever Global IP Ltd Oral care system
EP3888621A1 (en) 2020-04-02 2021-10-06 Unilever Global IP Ltd Oral care device
EP3888622A1 (en) 2020-04-02 2021-10-06 Unilever Global IP Ltd Oral care system
EP3888619A1 (en) 2020-04-02 2021-10-06 Unilever Global IP Ltd Oral care device
CN113995682A (en) * 2021-11-04 2022-02-01 浙江大学 Application of tooth restoration composition in tooth restoration
EP3302405B1 (en) * 2015-06-05 2023-08-23 Unilever IP Holdings B.V. Oral care device

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140154296A1 (en) * 2011-04-04 2014-06-05 Robert L. Karlinsey Dental compositions containing silica microbeads
US9724277B2 (en) * 2011-04-04 2017-08-08 Robert L. Karlinsey Microbeads for dental use
DE102015110367A1 (en) * 2015-06-26 2016-12-29 Karlsruher Institut für Technologie Online phosphorus detection by infrared spectroscopy
CN106380769A (en) * 2016-10-21 2017-02-08 浙江九天寰宇生物科技有限公司 Whitening gel for denture of tooth whitening kit and preparation method thereof
CN108264235B (en) * 2017-12-28 2021-04-06 东莞市鸿元医药科技有限公司 Preparation method and application of bioactive glass powder for promoting wound healing
CN110511060A (en) * 2019-08-22 2019-11-29 德化县顺尔美工艺品有限公司 One kind is imitative to twist tire ceramics and its manufacture craft
CN111494706A (en) * 2020-04-17 2020-08-07 中山职业技术学院 Porous modified amorphous calcium phosphate nano powder and preparation method and application thereof
CN111481740A (en) * 2020-04-17 2020-08-04 中山职业技术学院 High-dispersity amorphous calcium phosphate nano powder and preparation method and application thereof
EP4153320A1 (en) 2020-05-21 2023-03-29 Unilever IP Holdings B.V. Oral care composition
CA3220437A1 (en) 2021-05-20 2022-11-24 Smile Makers, Llc Oral hygiene compositions and methods of use
CN115887251B (en) * 2022-12-15 2023-07-04 金三江(肇庆)硅材料股份有限公司 Silicon dioxide-calcium sulfate composite particles and preparation method and application thereof

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4083955A (en) 1975-04-02 1978-04-11 The Procter & Gamble Company Processes and compositions for remineralization of dental enamel
DE3942643A1 (en) 1988-12-29 1990-07-05 Colgate Palmolive Co MOUTH CARE PRODUCTS
US5605675A (en) 1995-06-06 1997-02-25 Enamelon Inc. Processes and compositions for remineralization and prevention of demineralization of dental enamel
US5735942A (en) 1996-02-07 1998-04-07 Usbiomaterials Corporation Compositions containing bioactive glass and their use in treating tooth hypersensitivity
US6214321B1 (en) 1998-03-11 2001-04-10 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Remineralization of teeth
US6365132B1 (en) 1997-09-18 2002-04-02 Univ. Of Md., Baltimore Methods and compositions for whitening teeth
US20020064504A1 (en) 1999-06-23 2002-05-30 The Research Foundation Of State University Of New York Dental anti-hypersensitivity composition and method
WO2008015117A2 (en) 2006-08-01 2008-02-07 Unilever Plc Biomaterials, their preparation and use
WO2008068149A1 (en) 2006-12-05 2008-06-12 Unilever Plc Oral care product
US20090264291A1 (en) 1998-02-23 2009-10-22 Etienne Soudant Compositions comprising anti-proliferative agents and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143064A (en) * 1996-03-04 2000-11-07 Fp-Pigments Oy Pigment particles coated with precipitated calcium carbonate and a process for the preparation thereof
AU4083597A (en) * 1996-09-27 1998-04-17 Enamelon, Inc. Improved products and methods for the remineralization and prevention of demineralization of teeth
US5858333A (en) * 1998-08-07 1999-01-12 Enamelon, Inc. Two-part oral products and methods of using same to remineralize teeth
EP1731132B1 (en) * 2000-10-13 2008-12-10 Block Drug Company, Inc. Dental compositions for hypersensitive teeth
JP2003275600A (en) * 2002-03-19 2003-09-30 National Institute Of Advanced Industrial & Technology Visible ray responsive and adsorptive composite material
US20060115437A1 (en) * 2004-11-26 2006-06-01 Robert Hayman Dental whitening compositions
US10004604B2 (en) * 2006-09-08 2018-06-26 Kyocera Corporation Bioimplant for artifical joint with evanescent coating film
DE102007039335A1 (en) * 2007-08-20 2009-02-26 Henkel Ag & Co. Kgaa Luminescent composite materials

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4083955A (en) 1975-04-02 1978-04-11 The Procter & Gamble Company Processes and compositions for remineralization of dental enamel
DE3942643A1 (en) 1988-12-29 1990-07-05 Colgate Palmolive Co MOUTH CARE PRODUCTS
US5605675A (en) 1995-06-06 1997-02-25 Enamelon Inc. Processes and compositions for remineralization and prevention of demineralization of dental enamel
US5735942A (en) 1996-02-07 1998-04-07 Usbiomaterials Corporation Compositions containing bioactive glass and their use in treating tooth hypersensitivity
US6365132B1 (en) 1997-09-18 2002-04-02 Univ. Of Md., Baltimore Methods and compositions for whitening teeth
US20090264291A1 (en) 1998-02-23 2009-10-22 Etienne Soudant Compositions comprising anti-proliferative agents and use thereof
US6214321B1 (en) 1998-03-11 2001-04-10 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Remineralization of teeth
US20020064504A1 (en) 1999-06-23 2002-05-30 The Research Foundation Of State University Of New York Dental anti-hypersensitivity composition and method
WO2008015117A2 (en) 2006-08-01 2008-02-07 Unilever Plc Biomaterials, their preparation and use
WO2008068149A1 (en) 2006-12-05 2008-06-12 Unilever Plc Oral care product
WO2008068248A1 (en) 2006-12-05 2008-06-12 Unilever Plc Oral care product

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013013275A1 (en) * 2011-07-27 2013-01-31 B Athanassiadis Dental Pty Ltd Alkaline compositions and their dental and medical use
AU2012286596B2 (en) * 2011-07-27 2015-08-20 B Athanassiadis Dental Pty Ltd Alkaline compositions and their dental and medical use
US10064794B2 (en) 2012-12-24 2018-09-04 Colgate-Palmolive Company Oral care composition
WO2015036277A1 (en) * 2013-09-10 2015-03-19 Unilever N.V. Oral care composition
CN105517633A (en) * 2013-09-10 2016-04-20 荷兰联合利华有限公司 Oral care composition
EA033259B1 (en) * 2013-09-10 2019-09-30 Юнилевер Н.В. Oral care composition
CN105517633B (en) * 2013-09-10 2019-06-18 荷兰联合利华有限公司 Oral care composition
US10010491B2 (en) 2013-09-10 2018-07-03 Conopco Inc. Oral care composition
US9867764B2 (en) 2013-09-10 2018-01-16 Conopco, Inc. Oral care composition
US11602495B2 (en) 2013-12-20 2023-03-14 Colgate-Palmolive Company Core shell silica particles and use for malodor reduction
US11951196B2 (en) 2013-12-20 2024-04-09 Colgate-Palmolive Company Core shell silica particles and use for malodor reduction
US11324678B2 (en) 2013-12-20 2022-05-10 Colgate-Palmolive Company Core shell silica particles and uses thereof as an anti-bacterial agent
US10369091B2 (en) 2013-12-20 2019-08-06 Colgate-Palmolive Company Core shell silica particles and uses thereof as an anti-bacterial agent
US11400032B2 (en) 2013-12-20 2022-08-02 Colgate-Palmolive Company Tooth whitening oral care product with core shell silica particles
US10596084B2 (en) 2013-12-20 2020-03-24 Colgate-Palmolive Company Tooth whitening oral care product with core shell silica particles
WO2016180601A1 (en) 2015-05-13 2016-11-17 Unilever N.V. Oral care composition
WO2016180620A1 (en) * 2015-05-13 2016-11-17 Unilever N.V. Oral care composition
WO2016192924A1 (en) 2015-06-05 2016-12-08 Unilever Plc Oral care device
WO2016192925A1 (en) 2015-06-05 2016-12-08 Unilever Plc Oral care device
EP3302405B1 (en) * 2015-06-05 2023-08-23 Unilever IP Holdings B.V. Oral care device
US10595976B2 (en) 2015-06-05 2020-03-24 Conopco Inc. Oral care device
WO2017050528A1 (en) * 2015-09-24 2017-03-30 Unilever N.V. Oral care composition
WO2017080687A1 (en) 2015-11-10 2017-05-18 Unilever N.V. Oral care composition
WO2018224331A1 (en) * 2017-06-07 2018-12-13 Unilever N.V. Oral care composition
CN111050733A (en) * 2017-07-07 2020-04-21 荷兰联合利华有限公司 Oral care compositions
WO2019007695A1 (en) * 2017-07-07 2019-01-10 Unilever N.V. Oral care composition
CN111050733B (en) * 2017-07-07 2023-04-11 联合利华知识产权控股有限公司 Oral care compositions
WO2019029917A1 (en) * 2017-08-10 2019-02-14 Unilever N.V. Oral care composition
WO2020052855A1 (en) 2018-09-12 2020-03-19 Unilever Plc Oral care composition
WO2020212159A1 (en) 2019-04-17 2020-10-22 Unilever Plc Oral care product
EP3865112A1 (en) * 2020-02-13 2021-08-18 Xi'an University of Science and Technology Method for making composition for enamel regeneration
EP3888623A1 (en) 2020-04-02 2021-10-06 Unilever Global IP Ltd Oral care system
EP3888619A1 (en) 2020-04-02 2021-10-06 Unilever Global IP Ltd Oral care device
EP3888622A1 (en) 2020-04-02 2021-10-06 Unilever Global IP Ltd Oral care system
EP3888621A1 (en) 2020-04-02 2021-10-06 Unilever Global IP Ltd Oral care device
EP3888620A1 (en) 2020-04-02 2021-10-06 Unilever Global IP Ltd Oral care system
CN113995682A (en) * 2021-11-04 2022-02-01 浙江大学 Application of tooth restoration composition in tooth restoration

Also Published As

Publication number Publication date
SA111320297B1 (en) 2014-11-12
EP2613850B1 (en) 2016-11-23
BR112013004354A2 (en) 2016-05-10
CN107308010A (en) 2017-11-03
BR112013004354B8 (en) 2018-10-23
CN103079645A (en) 2013-05-01
US20130164359A1 (en) 2013-06-27
WO2012031785A3 (en) 2012-10-18
EP2613850A2 (en) 2013-07-17
BR112013004354B1 (en) 2017-12-05

Similar Documents

Publication Publication Date Title
EP2613850B1 (en) Composite particle active and method for making the same
EP2613756B1 (en) Oral care compositions for benefiting teeth
EP2699217B1 (en) Tooth remineralizing oral care compositions
EP3043868B1 (en) Oral care composition
CN110997072B (en) Oral care compositions
EP3648731B1 (en) Oral care composition
CN109890350B (en) Oral care compositions
US10010491B2 (en) Oral care composition
EP3554459B1 (en) Oral care composition
EP3352723B1 (en) Oral care composition
EP3374031B1 (en) Oral care composition
CN111093603B (en) Oral care compositions
WO2020099068A1 (en) Oral care composition
CN110573131B (en) Oral care compositions

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201180043399.6

Country of ref document: CN

REEP Request for entry into the european phase

Ref document number: 2011710153

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2011710153

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 13820154

Country of ref document: US

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11710153

Country of ref document: EP

Kind code of ref document: A2

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112013004354

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112013004354

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20130225